XENETIC BIOSCIENCES, INC. Increase (Decrease) in Accounts and Other Receivables
XENETIC BIOSCIENCES, INC. (XBIO) reported Increase (Decrease) in Accounts and Other Receivables of -$255.66 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2026-03-12
- XENETIC BIOSCIENCES, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-12-31 was -$780.07K, a 433.55% decline year-over-year.
- XENETIC BIOSCIENCES, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-09-30 was $372.51K.
- XENETIC BIOSCIENCES, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-06-30 was $260.23K, a 58.35% increase year-over-year.
- XENETIC BIOSCIENCES, INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-03-31 was -$108.33K.
- XENETIC BIOSCIENCES, INC. increase (decrease) in accounts and other receivables for fiscal 2025 was -$255.66K.
- XENETIC BIOSCIENCES, INC. increase (decrease) in accounts and other receivables for fiscal 2024 was -$181.87K, a 481.02% decline from fiscal 2023.
- XENETIC BIOSCIENCES, INC. increase (decrease) in accounts and other receivables for fiscal 2023 was $47.73K, a 53.99% decline from fiscal 2022.
- XENETIC BIOSCIENCES, INC. increase (decrease) in accounts and other receivables for fiscal 2022 was $103.74K.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 3 month as first filed | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 9 month as first filed | Increase (Decrease) in Accounts and Other Receivables 12 month | Increase (Decrease) in Accounts and Other Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$780.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$407.56K derived: sum of 2 quarters · filed 2026-03-12 | -$147.33K derived: sum of 3 quarters · filed 2026-03-12 | -$255.66K 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $372.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $632.74K derived: sum of 2 quarters · filed 2025-11-12 | $524.41K 10-Q · filed 2025-11-12 | $758.27K derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2025-06-30 | $260.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $151.90K 10-Q · filed 2025-08-12 | $385.77K derived: sum of 3 quarters · filed 2026-03-12 | -$142.53K derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2025-03-31 | -$108.33K 10-Q · filed 2025-05-13 | $125.53K derived: sum of 2 quarters · filed 2026-03-12 | -$402.76K derived: sum of 3 quarters · filed 2026-03-12 | -$238.42K derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2024-12-31 | $233.87K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$294.43K derived: sum of 2 quarters · filed 2026-03-12 | -$130.09K derived: sum of 3 quarters · filed 2026-03-12 | -$181.87K 10-K · filed 2026-03-12 | |||
| 2024-09-30 | -$528.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$363.95K derived: sum of 2 quarters · filed 2025-11-12 | -$415.74K 10-Q · filed 2025-11-12 | -$1.29M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $164.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $112.55K 10-Q · filed 2025-08-12 | -$764.18K derived: sum of 3 quarters · filed 2025-08-12 | -$602.65K derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | -$51.78K 10-Q · filed 2025-05-13 | -$928.52K derived: sum of 2 quarters · filed 2025-05-13 | -$766.99K derived: sum of 3 quarters · filed 2025-05-13 | -$324.50K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$876.73K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$715.21K derived: sum of 2 quarters · filed 2025-03-18 | -$272.71K derived: sum of 3 quarters · filed 2025-03-18 | $47.73K 10-K · filed 2025-03-18 | |||
| 2023-09-30 | $161.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $604.02K derived: sum of 2 quarters · filed 2024-11-12 | $924.47K 10-Q · filed 2024-11-12 | $1.16M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $442.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $762.94K 10-Q · filed 2024-08-13 | $999.93K derived: sum of 3 quarters · filed 2024-08-13 | $878.26K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $320.44K 10-Q · filed 2024-05-09 | $557.44K derived: sum of 2 quarters · filed 2024-05-09 | $435.76K derived: sum of 3 quarters · filed 2024-05-09 | $161.74K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $236.99K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $115.32K derived: sum of 2 quarters · filed 2024-03-21 | -$158.71K derived: sum of 3 quarters · filed 2024-03-21 | $103.74K 10-K · filed 2024-03-21 | |||
| 2022-09-30 | -$121.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$395.70K derived: sum of 2 quarters · filed 2023-11-09 | -$133.25K 10-Q · filed 2023-11-09 | -$481.74K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$274.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$11.58K 10-Q · filed 2023-08-10 | -$360.07K derived: sum of 3 quarters · filed 2023-08-10 | -$296.53K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $262.44K 10-Q · filed 2023-05-11 | $265.31K 10-Q · filed 2022-05-12 | -$86.05K derived: sum of 2 quarters · filed 2023-05-11 | -$22.50K derived: sum of 3 quarters · filed 2023-05-11 | -$133.29K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$348.49K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$284.95K derived: sum of 2 quarters · filed 2023-03-22 | -$395.74K derived: sum of 3 quarters · filed 2023-03-22 | -$286.01K 10-K · filed 2023-03-22 | -$4.06K 10-K · filed 2022-03-22 | ||
| 2021-09-30 | $63.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$47.24K derived: sum of 2 quarters · filed 2022-11-09 | $62.48K 10-Q · filed 2022-11-09 | -$43.07K 10-Q · filed 2021-11-12 | $9.87K derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | -$110.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.06K 10-Q · filed 2022-08-11 | -$53.67K derived: sum of 3 quarters · filed 2022-08-11 | -$159.13K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $109.73K 10-Q · filed 2022-05-12 | $57.12K derived: sum of 2 quarters · filed 2022-05-12 | -$48.35K derived: sum of 3 quarters · filed 2022-05-12 | -$302.38K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | -$52.61K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$158.08K derived: sum of 2 quarters · filed 2022-03-22 | -$412.11K derived: sum of 3 quarters · filed 2022-03-22 | -$325.66K 10-K · filed 2022-03-22 | |||
| 2020-09-30 | -$105.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$359.50K derived: sum of 2 quarters · filed 2021-11-12 | -$273.05K 10-Q · filed 2021-11-12 | $82.80K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$254.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$167.59K 10-Q · filed 2021-08-12 | $188.26K derived: sum of 3 quarters · filed 2021-08-12 | -$289.28K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $86.45K 10-Q · filed 2021-05-11 | $442.30K derived: sum of 2 quarters · filed 2021-05-11 | -$35.25K derived: sum of 3 quarters · filed 2021-05-11 | $203.31K derived: sum of 4 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $355.85K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$121.69K derived: sum of 2 quarters · filed 2021-03-16 | $116.86K derived: sum of 3 quarters · filed 2021-03-16 | $653.56K 10-K · filed 2021-03-16 | |||
| 2019-09-30 | -$477.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$238.99K derived: sum of 2 quarters · filed 2020-11-12 | $297.71K 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | $238.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $775.26K 10-Q · filed 2020-08-12 | |||||
| 2019-03-31 | $536.70K 10-Q · filed 2020-05-14 | ||||||
| 2018-12-31 | $251.80K 10-K · filed 2020-03-26 | ||||||
| 2017-12-31 | -$280.63K 10-K · filed 2019-03-29 | ||||||
| 2016-12-31 | $234.92K 10-K · filed 2018-03-30 | ||||||
| 2016-06-30 | -$80.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$36.99K 10-Q · filed 2016-08-15 | -$7.76K derived: sum of 3 quarters · filed 2017-03-31 | $90.36K derived: sum of 4 quarters · filed 2017-03-31 | |||
| 2016-03-31 | $43.93K 10-Q · filed 2016-05-16 | $73.16K derived: sum of 2 quarters · filed 2017-03-31 | $171.28K derived: sum of 3 quarters · filed 2017-03-31 | -$74.64K derived: sum of 4 quarters · filed 2017-03-31 | |||
| 2015-12-31 | $29.23K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $127.35K derived: sum of 2 quarters · filed 2017-03-31 | -$118.57K derived: sum of 3 quarters · filed 2017-03-31 | -$21.23K 10-K · filed 2017-03-31 | |||
| 2015-09-30 | $98.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$147.81K derived: sum of 2 quarters · filed 2016-08-15 | -$50.46K 10-Q · filed 2015-11-16 | -$186.97K derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-06-30 | -$245.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$148.58K 10-Q · filed 2016-08-15 | -$285.10K derived: sum of 3 quarters · filed 2016-08-15 | -$411.72K derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | $97.35K 10-Q · filed 2016-05-16 | -$39.17K derived: sum of 2 quarters · filed 2016-05-16 | -$165.79K derived: sum of 3 quarters · filed 2016-05-16 | -$136.76K derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | -$136.51K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$263.14K derived: sum of 2 quarters · filed 2016-03-30 | -$234.11K derived: sum of 3 quarters · filed 2016-03-30 | $24.47K 10-K · filed 2016-03-30 | |||
| 2014-09-30 | -$126.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$97.59K derived: sum of 2 quarters · filed 2015-11-16 | $160.98K 10-Q · filed 2015-11-16 | $156.50K derived: sum of 4 quarters · filed 2015-11-16 | |||
| 2014-06-30 | $29.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | $287.61K 10-Q · filed 2015-08-19 | $283.12K derived: sum of 3 quarters · filed 2015-08-19 | $335.28K derived: sum of 4 quarters · filed 2015-08-19 | |||
| 2014-03-31 | $258.58K 10-Q · filed 2015-05-20 | $254.09K derived: sum of 2 quarters · filed 2015-07-20 | $306.25K derived: sum of 3 quarters · filed 2015-07-20 | $391.28K derived: sum of 4 quarters · filed 2015-07-20 | |||
| 2013-12-31 | -$4.49K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-20 | $47.67K derived: sum of 2 quarters · filed 2015-07-20 | $132.70K derived: sum of 3 quarters · filed 2015-07-20 | $7.52K 10-K · filed 2015-07-20 | |||
| 2013-09-30 | $52.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $137.19K derived: sum of 2 quarters · filed 2014-11-14 | $12.00K 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | $85.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$40.15K 10-Q · filed 2014-08-14 | |||||
| 2013-03-31 | -$125.19K 10-Q · filed 2014-05-20 | ||||||
| 2012-12-31 | $31.70K 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |